| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |